Immediate Impact
2 by Nobel laureates 11 from Science/Nature 67 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Jan Spanholtz being referenced
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
2022
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jan Spanholtz | 1157 | 899 | 310 | 38 | 1.4k | |
| Srinivas S. Somanchi | 1085 | 862 | 192 | 30 | 1.3k | |
| Sijie Lu | 895 | 679 | 168 | 23 | 1.2k | |
| Felix S. Lichtenegger | 680 | 661 | 427 | 35 | 1.3k | |
| Qing Zhou | 918 | 677 | 223 | 29 | 1.3k | |
| Laura E. Bendzick | 1092 | 953 | 106 | 25 | 1.4k | |
| Ian J. Okazaki | 1588 | 1231 | 486 | 24 | 1.9k | |
| Bartosz Grzywacz | 938 | 587 | 259 | 31 | 1.2k | |
| Tim Luetkens | 710 | 645 | 412 | 57 | 1.3k | |
| Melissa M. Berrien-Elliott | 1448 | 969 | 244 | 48 | 1.8k | |
| Kyoko Masuda | 1071 | 605 | 277 | 46 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...